Trio-Tech International (NYSE:TRT – Get Free Report) fell 4.5% on Thursday . The stock traded as low as $5.13 and last traded at $5.13. 749 shares changed hands during mid-day trading, a decline of 90% from the average session volume of 7,778 shares. The stock had previously closed at $5.37.
Analyst Upgrades and Downgrades
Separately, Wall Street Zen assumed coverage on Trio-Tech International in a research report on Thursday, May 22nd. They issued a “buy” rating for the company.
Check Out Our Latest Research Report on Trio-Tech International
Trio-Tech International Stock Performance
Hedge Funds Weigh In On Trio-Tech International
An institutional investor recently raised its position in Trio-Tech International stock. Dimensional Fund Advisors LP raised its holdings in shares of Trio-Tech International (NYSE:TRT – Free Report) by 7.0% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 122,064 shares of the company’s stock after buying an additional 8,030 shares during the quarter. Dimensional Fund Advisors LP owned about 2.87% of Trio-Tech International worth $709,000 as of its most recent filing with the Securities & Exchange Commission. Hedge funds and other institutional investors own 16.03% of the company’s stock.
Trio-Tech International Company Profile
Trio-Tech International, together with its subsidiaries, offers manufacturing, testing, and distribution services to the semiconductor industry. It operates through four segments: Manufacturing, Testing Services, Distribution, and Real Estate. The company develops and manufactures test equipment used in front-end and back-end manufacturing processes of semiconductors.
Further Reading
- Five stocks we like better than Trio-Tech International
- What is the S&P 500 and How It is Distinct from Other Indexes
- Ignore the Noise—Samsara Stock Is Still a Strong Buy
- What Investors Need to Know to Beat the Market
- 3 Stocks Set to Double—And There’s Still Time to Buy
- What Investors Must Know About Over-the-Counter (OTC) Stocks
- Analysts Can’t Get Enough of These Little-Known Biopharma Stocks
Receive News & Ratings for Trio-Tech International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trio-Tech International and related companies with MarketBeat.com's FREE daily email newsletter.